You might also like
No business description found.
| Name | Position | External Roles | Short Bio | |
|---|---|---|---|---|
R. Jeffrey Bailly ExecutiveBoard | Chairman and Chief Executive Officer | None | R. Jeffrey Bailly has been with UFPT since 1988, serving as CEO since 1995 and Chairman since 2006. He has a background in operations, accounting, and finance. | View Report → |
Christopher P. Litterio Executive | General Counsel, Secretary, and Senior Vice President of Human Resources | None | Christopher P. Litterio joined UFPT in 2017, overseeing legal matters and human resources. He has a background in business litigation and employment law. | |
Jason Holt Executive | Vice President and Chief Commercial Officer | None | Jason Holt joined UFPT in 2018 and is responsible for the Advanced Components business. He previously held leadership roles at Illinois Tool Works. | |
Mitchell C. Rock Executive | President | Board Member at Outlook Amusements, Inc. | Mitchell C. Rock joined UFPT in 1991 and became President in 2024. He has led various sales and marketing roles and was President of UFP MedTech. | |
Ronald J. Lataille Executive | Chief Financial Officer and Senior Vice President | None | Ronald J. Lataille joined UFPT in 1997 as CFO. He has extensive experience in financial management and strategic growth. | |
Steven G. Cardin Executive | Vice President and Chief Operating Officer, MedTech | None | Steven G. Cardin joined UFPT in 2019, bringing 28 years of experience in the medical device industry. He focuses on cleanroom manufacturing and medical device production. | |
Cynthia L. Feldmann Board | Director | Board Member at Alexandria Real Estate Equities, Inc. and STERIS PLC; Trustee at Falmouth Academy | Cynthia L. Feldmann has been a director at UFPT since 2017. She has a background in accounting, finance, and public company governance. | |
Daniel C. Croteau Board | Director | Board Member at Corza Medical, Resonetics, and Inventus Power | Daniel C. Croteau has been a director at UFPT since 2015. He has extensive experience in the medical device industry and has held various leadership roles. | |
Joseph John Hassett Board | Director | Senior Vice President and Chief Transformation Officer at Analog Devices Inc. | Joseph John Hassett has been a director at UFPT since 2022. He has a background in strategic and operational leadership, particularly in integrating large business acquisitions. | |
Marc Kozin Board | Director | Chairman of Vascular Biogenics; Board Member at Healthcare Royalty Partners | Marc Kozin has been a director at UFPT since 2006. He has a background in strategic planning and leadership consulting. | |
Symeria Hudson Board | Director | President and CEO of United Way Miami; Executive Board Member at MTF Biologics; Operating Advisor at Revival Healthcare Partners | Symeria Hudson has been a director at UFPT since 2022. She has leadership experience in healthcare and nonprofit sectors. | |
Thomas Oberdorf Board | Director | CEO and Chairman of SIRVA, Inc. | Thomas Oberdorf has been a director at UFPT since 2004. He has extensive experience in finance and public company operations. |
Notable M&A activity and strategic investments in the past 3 years.
| Company | Year | Details |
|---|---|---|
AQF Medical | 2024 | Completed on August 23, 2024, with an aggregate cash purchase price of €43.0 million (≈$47.8 million) subject to working capital and liability adjustments (approx. $900,000 downward adjustment); the deal, valued at 12.3x adjusted EBITDA, expands UFP’s expertise in custom-engineered foam/thermoplastic components and includes a joint venture in Asia. |
Welch Fluorocarbon | 2024 | Completed on July 15, 2024, for a base price of $34.6 million in cash with up to an additional $6.0 million contingent consideration (fair valued at about $800,000) and a working capital adjustment of around $200,000; the acquisition, including a $3.2 million real estate purchase, adds thermoformed, heat-sealed implantable device components to UFP’s MedTech portfolio. |
AJR Enterprises | 2024 | Completed on July 1, 2024, with a $110 million cash purchase price subject to working capital adjustments and an escrow for indemnification; the acquisition of a manufacturer specializing in single-use safe patient handling systems strategically broadens UFP’s offerings in patient surfaces and transfer devices, financed via UFP’s amended credit agreement. |
Marble Medical | 2024 | Completed on June 24, 2024, for an initial cash payment of $4.5 million with additional contingent consideration of up to $0.5 million, representing approximately 4.5x adjusted EBITDA; the deal brings capabilities in biocompatible adhesives and precision die-cutting, and includes the acquisition of manufacturing, warehouse, and office real estate. |
Advant Medical Ltd. | 2022 | Completed on March 16, 2022, with a purchase price of €19.0 million (≈$21.2 million) in cash plus working capital adjustments; the acquisition enhanced UFP’s medical device manufacturing (clean room and injection molding capabilities) and added customer relationships and assets (including $7.14 million in goodwill), aligning with its MedTech strategy. |
DAS Medical | 2021 | Completed on December 22, 2021, with a total estimated cost of approximately $105 million (including $75 million cash, a $20 million earn-out potential, and $10 million held in escrow) and non-competition agreements; the deal strengthens UFP’s position in single-use surgical covers, robotic drapes, and fluid control pouches while expanding its manufacturing footprint. |
Contech Medical | 2021 | Completed on October 12, 2021, for a base price of $9.5 million in cash plus an additional $5 million contingent on EBITDA targets; the acquisition provides enhanced Class III medical device packaging capabilities with significant customer overlap (70% of its customers already served by UFP), expected to be immediately accretive to earnings. |